Arecor is a globally focused biopharmaceutical company that is targeting improving patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying the Group's innovative proprietary formulation technology platform, Arestat, the Group is developing an internal portfolio of proprietary products, as well as working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of their partners' therapeutic products, supported by an extensive patent portfolio.
Registrars:
Key Personnel
CEO:
Sarah Jennifer Howell
CFO:
David Ellam
Non-Executive Director:
Alan Edward Smith
Non-Executive Chairman:
Andrew Richards
Independent Non-Executive Director:
Jeremy Lewis Morgan, Mohammed Sohail Fazeli, Christine Helen Soden
Contact Details
Address:
Chesterford Research Park, Little Chesterford, Saffron Walden, United Kingdom